Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

被引:399
|
作者
Fairfoul, Graham [1 ]
McGuire, Lynne I. [1 ]
Pal, Suvankar [1 ,2 ]
Ironside, James W. [1 ]
Neumann, Juliane [3 ]
Christie, Sharon [4 ]
Joachim, Catherine [4 ]
Esiri, Margaret [4 ]
Evetts, Samuel G. [3 ]
Rolinski, Michal [3 ]
Baig, Fahd [3 ]
Ruffmann, Claudio [3 ]
Wade-Martins, Richard [5 ]
Hu, Michele T. M. [3 ]
Parkkinen, Laura [3 ]
Green, Alison J. E. [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Natl CJD Res & Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Western Gen Hosp, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Parkinsons Dis Ctr, Level 6 West Wing, Oxford OX3 9DU, England
[4] Univ Oxford, John Radcliffe Hosp, Oxford Project Investigate Memory & Ageing OPTIMA, Nuffield Dept Clin Neurosci, Level 6 West Wing, Oxford OX3 9DU, England
[5] Univ Oxford, Oxford Parkinsons Dis Ctr, Dept Physiol Anat & Genet, Le Gros Clark Bldg,South Parks Rd, Oxford OX1 3QX, England
来源
基金
英国医学研究理事会;
关键词
SLEEP BEHAVIOR DISORDER; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; BIOMARKERS; COHORT;
D O I
10.1002/acn3.338
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.
引用
收藏
页码:812 / 818
页数:7
相关论文
共 50 条
  • [21] In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson's disease
    Shin, C.
    Han, J. Y.
    Choi, Y. P.
    Kim, S. I.
    Park, S. H.
    Yang, H. K.
    Lee, H. J.
    Kong, S. H.
    Suh, Y. S.
    Kim, H. J.
    Jeon, B.
    MOVEMENT DISORDERS, 2022, 37 : S524 - S524
  • [22] Cutaneous Alpha-Synuclein Detection in Patients with Suspected Synucleinopathies
    Gibbons, Christopher
    Bellaire, Bailey
    Freeman, Roy
    Levine, Todd
    NEUROLOGY, 2022, 98 (18)
  • [23] Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies
    Liu, Xiaoguang
    Hebron, Michaeline
    Shi, Wangke
    Lonskaya, Irina
    Moussa, Charbel E. -H.
    HUMAN MOLECULAR GENETICS, 2019, 28 (04) : 548 - 560
  • [24] In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson's disease
    Shin, Chaewon
    Han, Jung-Youn
    Kim, Seong-Ik
    Park, Sung-Hye
    Yang, Han-Kwang
    Lee, Hyuk-Joon
    Kong, Seong-Ho
    Suh, Yun-Suhk
    Kim, Han-Joon
    Choi, Young Pyo
    Jeon, Beomseok
    PARKINSONISM & RELATED DISORDERS, 2022, 103 : 23 - 28
  • [25] Real Time Quaking Induced Conversion (RT-QuIC) for Skin Alpha-Synuclein Seeding Activity in Parkinson Disease Versus Controls
    Gunzler, Steven
    Tatsuoka, Curtis
    Elkasaby, Mohamed
    Wang, Alexander
    Chen, Shu
    Wang, Zerui
    Zou, Wenquan
    NEUROLOGY, 2022, 98 (18)
  • [26] Achieving an optimal profile for immunotherapy of alpha-synucleinopathies: Rational generation of monoclonal antibodies selective for pathogenic forms of alpha-synuclein
    Kaplan, Johanne
    Gibbs, Ebrima
    Zhao, Beibei
    Wang, Jing
    Shyu, Clay
    Plotkin, Steven
    Cashman, Neil
    NEUROLOGY, 2020, 94 (15)
  • [27] Cutaneous Alpha-Synuclein Deposition Across the Synucleinopathies
    Gibbons, Christopher
    Wang, Ningshan
    Rajan, Sharika
    Kern, Drew
    Palma, Jose-Alberto
    Kaufmann, Horacio
    Freeman, Roy
    NEUROLOGY, 2020, 94 (15)
  • [28] Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
    Sandoval, Ivette M.
    Marmion, David J.
    Meyers, Kimberly T.
    Manfredsson, Fredric P.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S189 - S197
  • [29] Biochemical Differences in Pathologic alpha-Synuclein in Synucleinopathies
    Yamasaki, Tritia R.
    Welleford, Andrew S.
    Gerhardt, Greg A.
    ANNALS OF NEUROLOGY, 2017, 82 : S180 - S180
  • [30] RT-QuIC for detection of pathological α-synuclein in the olfactory mucosa and CSF of Parkinson's disease patients
    Tommasini, V.
    Bongianni, M.
    Catalan, M.
    Perra, D.
    Polverino, P.
    Bertolotti, C.
    Baruca, R.
    Bellavita, G.
    Antonutti, L.
    Zanusso, G.
    Manganotti, P.
    MOVEMENT DISORDERS, 2023, 38 : S109 - S110